Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.